May 05, 2020
Vicore Pharma receives regulatory approval to start phase II clinical trial with VP01 (C21) in patients with IPF
Media
May 05, 2020
Interim report January – March 2020
May 05, 2020
Nordic Nanovector Announces US Patent Granted Covering the Use of Betalutin® to Sensitise B-Cell Cancer Cells to CD20 Immunotherapy
May 04, 2020
Nordic Nanovector Announces Changes to its Executive Management Team
May 04, 2020
Vicore offers advance voting in connection with the 2020 AGM
May 04, 2020
Targovax releases update for mesothelioma trial combining ONCOS-102 and chemotherapy
April 30, 2020
Targovax ASA appoints Dr Victor Levitsky as Chief Scientific Officer
April 29, 2020
BONESUPPORT HOLDING AB (publ) – Interim Report Q1 2020 – invitation to conference call and webcast
April 29, 2020
BONESUPPORT appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North America
April 29, 2020
Targovax ASA: Invitation to online presentation of Targovax’s first quarter 2020 results, Thursday 7 May